Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-14

FDA Approved: SILODOSIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original application for generic silodosin for the treatment of signs and symptoms of benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

ORIG AP for SILODOSIN (SILODOSIN)